A detailed history of Globeflex Capital L P transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 1,210 shares of AMPH stock, worth $47,335. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,210
Previous 51 2272.55%
Holding current value
$47,335
Previous $2,000 2800.0%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.99 - $50.09 $42,871 - $58,054
1,159 Added 2272.55%
1,210 $58,000
Q2 2024

Aug 13, 2024

SELL
$38.65 - $43.48 $89,088 - $100,221
-2,305 Reduced 97.84%
51 $2,000
Q2 2023

Aug 14, 2023

SELL
$35.77 - $58.38 $3.11 Million - $5.07 Million
-86,836 Reduced 97.36%
2,356 $135,000
Q1 2023

May 12, 2023

BUY
$27.99 - $37.92 $645,729 - $874,814
23,070 Added 34.89%
89,192 $3.34 Million
Q4 2022

Feb 10, 2023

SELL
$27.93 - $31.27 $171,238 - $191,716
-6,131 Reduced 8.49%
66,122 $1.85 Million
Q2 2022

Aug 15, 2022

SELL
$29.79 - $42.29 $1,400 - $1,987
-47 Reduced 0.07%
72,253 $2.51 Million
Q1 2022

May 13, 2022

SELL
$22.96 - $36.45 $1,056 - $1,676
-46 Reduced 0.06%
72,300 $2.6 Million
Q4 2021

Feb 10, 2022

BUY
$18.14 - $23.29 $1.01 Million - $1.3 Million
55,889 Added 339.61%
72,346 $1.69 Million
Q2 2021

Aug 12, 2021

BUY
$17.11 - $20.92 $281,579 - $344,280
16,457 New
16,457 $332,000
Q4 2020

Feb 11, 2021

SELL
$17.76 - $21.24 $383,509 - $458,656
-21,594 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$14.25 - $22.46 $307,714 - $485,001
21,594 New
21,594 $485,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.